Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain.
R IbáñezMareque MaríaR GranadosD AndíaM García-RojoJ C QuílezI OyagüezPublished in: BMC women's health (2021)
Assuming that 70% of women from 35 to 65 years attend the CCS programme, the cost of screening up to the first colposcopy using AHPV would provide cost savings of up to € 41.9 million versus DNA tests in Spain.